News | Stroke | August 26, 2024

AI Tool Helps Predict Stroke Outcomes

AI tool predicts stroke outcomes after arterial clot removal with 78% accuracy.

Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can accurately project post-surgical outcomes for some patients with large vessel occlusion (LVO) stroke using computed tomography angiography (CTA) scans taken at admission. 

"The deep learning model developed by our research team is the first step toward intelligent machinization of stroke neuroimaging protocol," said Sam Payabvash, M.D., Associate Professor of Radiology and Biomedical Imaging and senior author of the study. 

Using data from patients undergoing thrombectomy from 2014 to 2020, the Yale team trained three different models on admission CTA scans with and without data including time to surgery, age, sex and NIH stroke scale score. Researchers say the new tool would enable quick and accurate decision-making, with an established 'treatment trigger' to activate the treatment chain after surgery.

"We developed an end-to-end fully automated deep learning model that can predict stroke outcomes from readily available admission brain images and treatment success scenarios, with 78% accuracy in independent validation," Payabvash said.

"It’s worth noting that the model can solely rely on CT angiography scans of the brain, which are invariably present at the time of stroke diagnosis," he added. "Therefore, our model based on imaging information can provide rapid, objective predictions regardless of local expertise and other variabilities, guiding treatment in resource challenged communities.”

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now